High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in Japan

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Nishijima, Takeshi ^a,b   Gatanaga, Hiroyuki ^a,b   Komatsu, Hirokazu ^c   Takano, Misao ^a   Ogane, Miwa ^a   Ikeda, Kazuko ^a   Oka, Shinichi ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; METHAMPHETAMINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG ABUSE PATTERN; FEMALE; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE;

ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84892412595     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081960     Document Type: Article

References (30)

1. Lehman JS, Allen DM, Green TA, Onorato IM (1994) HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch. AIDS 8: 1465-1469.
2. Hahn RA, Onorato IM, Jones TS, Dougherty J (1989) Prevalence of HIV infection among intravenous drug users in the United States. JAMA 261: 2677-2684.
3. Magnani R, Sabin K, Saidel T, Heckathorn D (2005) Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19 Suppl 2: S67-72.
4. Wada K (2011) The history and current state of drug abuse in Japan. Ann N Y Acad Sci 1216: 62-72.
5. Tominaga M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, et al. (2009) Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002-2004. Soc Psychiatry Psychiatr Epidemiol 44: 777-783.
6. Wood E, Montaner JS, Tyndall MW, Schechter MT, O'Shaughnessy MV, et al. (2003) Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis 188: 1164-1170.
7. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, et al. (1998) Barriers to use of free antiretroviral therapy in injection drug users. JAMA 280: 547-549.
8. Malta M, Magnanini MM, Strathdee SA, Bastos FI (2010) Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 14: 731-747.
9. Horstmann E, Brown J, Islam F, Buck J, Agins BD (2010) Retaining HIVinfected patients in care: Where are we? Where do we go from here? Clin Infect Dis 50: 752-761.
10. Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, et al. (2009) Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med 10: 407-416.
11. Milloy MJ, Marshall BD, Kerr T, Buxton J, Rhodes T, et al. (2012) Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS 26: 1049-1063.
12. Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, et al. (2003) Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362: 1267-1274.
13. Nishijima T, Gatanaga H, Komatsu H, Tsukada K, Shimbo T, et al. (2012) Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naive patients with HIV infection. PLoS One 7: e29977.
14. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, et al. (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835.
15. Hidaka Y, Ichikawa S, Koyano J, Urao M, Yasuo T, et al. (2006) Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan. BMC Public Health 6: 239.
16. Nishijima T, Gatanaga H, Komatsu H, Takano M, Ogane M, et al. (2013) Illicit Drug Use Is a Significant Risk Factor for Loss to Follow Up in Patients with HIV-1 Infection at a Large Urban HIV Clinic in Tokyo. PLoS One 8: e72310.
17. Millett GA, Peterson JL, Wolitski RJ, Stall R (2006) Greater risk for HIV infection of black men who have sex with men: a critical literature review. Am J Public Health 96: 1007-1019.
18. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, et al. (2009) Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 38: 1624-1633.
19. Chen YM, Kuo SH (2007) HIV-1 in Taiwan. Lancet 369: 623-625.
20. Qian HZ, Stinnette SE, Rebeiro PF, Kipp AM, Shepherd BE, et al. (2011) The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abuse Treat 41: 14-20.
21. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO (2009) Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials 10: 299-305.
22. Rice BD, Delpech VC, Chadborn TR, Elford J (2011) Loss to follow-up among adults attending human immunodeficiency virus services in England, Wales, and Northern Ireland. Sex Transm Dis 38: 685-690.
23. Ndiaye B, Ould-Kaci K, Salleron J, Bataille P, Bonnevie F, et al. (2009) Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006. Antivir Ther 14: 567-575.
24. Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, et al. (2008) Loss to follow-up in an international, multicentre observational study. HIV Med 9: 261-269.
25. Lebouche B, Yazdanpanah Y, Gerard Y, Sissoko D, Ajana F, et al. (2006) Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med 7: 140- 145.
26. Latkin CA, Knowlton AR, Sherman S (2001) Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. J Subst Abuse 13: 89-102.
27. Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, et al. (2010) Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health 87: 480-485.
28. Mansergh G, Shouse RL, Marks G, Guzman R, Rader M, et al. (2006) Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 82: 131-134.
29. Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, et al. (2012) Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 23: 37-44.
30. Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, et al. (2011) Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil 2: 173-180.